You are here: Industry Insights > Diabetes

News List

Telemedicine Visits Comparable for Glycemic Control in T1DM drugs
January 20, 2020
Among patients with type 1 diabetes and suboptimal glycemic control, replacement of an intermediate face-to-face visit with a telemedicine session did not affect outcomes, according to a study published online January in Diabetes Care.
FDA approves Novo Nordisk’s Fiasp for diabetic children pharmaceutical-technology
January 09, 2020
Danish pharmaceutical company Novo Nordisk has secured US Food and Drug Administration (FDA) approval for Fiasp as a mealtime insulin option for diabetic children.
Study Explores Factors Affecting Glycemic Control in T1DM drugs
January 07, 2020
Patients with type 1 diabetes with optimal and suboptimal glycemic control differ with respect to clinical and health care utilization factors, according to a study published online December in Diabetes, Obesity and Metabolism.
New Continuous Glucose Monitor May Cut Hypoglycemia in T1DM drugs
January 06, 2020
Intermittently scanned continuous glucose monitoring (isCGM) results in higher treatment satisfaction among adults with type 1 diabetes, according to a study published online December in Diabetes Care.
Treating Oral Disease Could Yield T2DM-Related Cost Savings drugs
January 06, 2020
Providing nonsurgical periodontal treatment to patients with type 2 diabetes (T2D) and periodontitis may significantly reduce tooth loss and diabetes-related microvascular diseases via improved glycemic control.
Diabetes Mellitus May Increase Risk for Developing Heart Failure drugs
January 03, 2020
Patients with diabetes mellitus have an increased risk for heart failure, even in the absence of diastolic dysfunction ...
Big Advances Made Against Diabetes in 2019 drugs
January 02, 2020
A new artificial pancreas system, drugs that help control blood sugar and protect the heart and the kidneys, a new medication that delays type 1 diabetes ...
High Lipoprotein(a) Is Risk Factor for CVD in Type 1 Diabetes drugs
December 31, 2019
For patients with type 1 diabetes, lipoprotein(a) [Lp(a)] is a significant risk factor for macrovascular disease, albuminuria, and calcified aortic valve disease ...
Bariatric Surgery in Teens May Cut Diabetic Kidney Disease Risk drugs
December 30, 2019
Among obese adolescents with type 2 diabetes, metabolic bariatric surgery is associated with decreased rates of hyperfiltration and elevated urinary albumin excretion (UAE) ...
HbA1c Minimally Adds to CVD Risk Prediction in Prediabetes drugs
December 27, 2019
For individuals with prediabetes, hemoglobin A1c (HbA1c) minimally adds to cardiovascular disease (CVD) risk prediction, according to a study published online December in Diabetes Care.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page